Drug recall D-0277-2021

Class II Terminated reported Mar 3, 2021

Product

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single-Use Vials per tray (NDC 0703-4502-04), Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618.

Reason for recall

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Lots and codes

Lot # 31325042B, exp. date 06/2021 31325336B, exp. date 07/2021 31326042B, exp. date 10/2021 31326137B, exp. date 11/2021 31326230B, exp. date 12/2021 31323816B, exp. date 02/2021

Recall details

Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Quantity
29,357 vials
Distribution
Product was distributed nationwide in the USA and Puerto Rico.
Type
Voluntary: Firm initiated
Recall initiated
February 10, 2021
Terminated
May 15, 2024

Related products